|
Written by Graham Ruecroft
|
|
Thursday, 11 June 2009 08:18 |

ProsonitronTM, DISCUS®, SAXTM, UMAX® SAXTM and PRT based process technologies are proprietary "Solution-to-Particle" methods for controlling crystal size, shape and polymorph for APIs and helping in the making better medicines. Technologies offer dose-to-dose uniformity, formulation consistency, stability and 200% performance increase of inhaled APIs compared to micronized. Combination particles of multiple APIs can be manufactured.
|
|
Last Updated on Friday, 26 February 2010 12:57 |